Immune checkpoint inhibitors vs any first‐line chemotherapy
Time to progression · participants with advanced or metastatic muscle invasive bladder cancer
Immune checkpoint inhibitors probably leads to higher time to disease progression Range of compared with any first‐line chemotherapy (moderate certainty).
1 finding from 1 review
- Immunotherapy for advanced or metastatic urothelial carcinoma 2023 · Cochrane Headline outcomes onlyHR 1.33 [1.17, 1.5]2 studies · 1349 participantsModerate